DSP Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • 1.15 %Nav, as on 16-04-2021

  • Previous Nav

  • Net Change on 16-04-2021

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary investment objective of the scheme is to seek to generate consistent returns bypredominantly investing in equity and equity related securities of pharmaceutical and healthcarecompanies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
S&P BSE Health Care 8.99 4.41 53.44 18.47 8.21 15.16

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 51.83 23.60 14.87 1.94 4,260.99
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 52.36 19.39 8.33 2.14 1,563.95
UTI Healthcare Fund - Regular Plan - Growth Option Aug 01, 2005 50.51 20.51 10.96 2.33 618.13
Tata India Pharma & Healthcare Fund-Regular Plan-Growth Dec 28, 2015 46.09 21.53 10.33 2.63 435.03

Fund Holdings as on 31-March-2021

  • Cipla Limited

  • Lupin Limited

  • Sun Pharmaceutical Industries Limited

  • Dr. Reddy's Laboratories Limited

  • IPCA Laboratories Limited

  • TREPS / Reverse Repo Investments / Corporate Debt Repo

  • Apollo Hospitals Enterprise Limited

  • Divi's Laboratories Limited

  • Max Healthcare Institute Limited

  • Procter & Gamble Health Limited

  • JB Chemicals & Pharmaceuticals Limited

  • Torrent Pharmaceuticals Limited

  • Dr. Lal Path Labs Ltd.

  • ICICI Lombard General Insurance Company Limited

  • Intuitive Surgical Inc

  • Abiomed Inc

  • Abbott Laboratories

  • Narayana Hrudayalaya Ltd.

  • Indoco Remedies Limited

  • Syngene International Limited

  • Alkem Laboratories Limited

  • Alembic Pharmaceuticals Limited

  • Aarti Drugs Limited

  • Unichem Laboratories Limited

  • Abbott India Limited

  • Net Receivables/Payables

View More

  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Insurance

View More

Fund Manager

  • Cash

  • Equity

View More

About DSP Healthcare Fund

Scheme Analysis

DSP Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to DSP Mutual Fund. It was launched on 30-Nov-2018 and currently has an AUM of ₹1,109.58 crore. DSP Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and S&P BSE Health Care as secondary index.

The NAV of DSP Healthcare Fund ended up ₹0.23(1.15%)yesterday to ₹20.327.

Among its top 3 holdings the fund has exposure to Cipla Limited, and

The DSP Healthcare Fund is managed by Vinit Sambre and Jay Kothari.

Fund House Contact

Mafatlal Centre, 10th Floor, Nariman Point, Mumbai - 400 021

+91 (22) 66578000
+91 (22) 66578181